Prot#CRN00808-02: A Double-blind, Placebo-controlled, Randomized Withdrawal Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients with Acromegaly that are Responders to Octreotide Lar or Landreotide (ACROBAT EVOLVE)

Project: Research project

Project Details

StatusFinished
Effective start/end date8/6/19 → 8/6/22

Funding

  • Accelsiors CRO and Consultancy Services Ltd. (Prot#CRN00808-02 // Prot#CRN00808-02)
  • Crinetics Pharmaceuticals, Inc. (Prot#CRN00808-02 // Prot#CRN00808-02)